CorMedix Inc. reports Q3 financials, DefenCath drives growth By Investing.com
In a recent financial results conference call, CorMedix Inc. (NYSE American: CRMD) reported substantial progress in the third quarter of ...
Monday, March 17, 2025
Tag: DefenCath
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.